Page last updated: 2024-08-23

alpidem and Interstitial Cell Tumor

alpidem has been researched along with Interstitial Cell Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altomare, CD; Cutrignelli, A; Denora, N; Franco, M; Laquintana, V; Lopedota, A; Midzak, A; Papadopoulos, V1

Other Studies

1 other study(ies) available for alpidem and Interstitial Cell Tumor

ArticleYear
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Aug-30, Volume: 76

    Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Dose-Response Relationship, Drug; Hormone Antagonists; Hydrogen Bonding; Imidazoles; Leydig Cell Tumor; Ligands; Male; Mice; Molecular Structure; Neoplasms, Hormone-Dependent; Pyridines; Receptors, GABA; Steroid Synthesis Inhibitors; Structure-Activity Relationship; Testicular Neoplasms

2015